Edward Benz

Mount Desert Island Hospital, Inc. provides healthcare services. Its services include anesthesiology, cardiology, dentistry, gastroenterology, gynecology, neurology, obstetrics, oncology, pediatrics and podiatry services. The company was founded in 1897 and is headquartered in Bar Harbor, ME.

The Mount Desert Island Biological Laboratory is a non profit biomedical research institution. It helps to improve human health and well-being through basic research, education, and development ventures. The company was founded in 1898 and is headquartered in Bar Harbor, ME.

Massachusetts Life Sciences Center functions as a pension/retirement fund. The private company is based in Waltham, MA. The CEO of the company is Kenn Turner.

F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.

Association of American Cancer Institutes operates as a membership association of academic and freestanding cancer research centers in the United States. It comprises 98 cancer research centers. The company is headquartered in Pittsburgh, PA.

The New England Journal of Medicine develops medical software.

Knowledge to Practice, Inc. provides clinical education services. It specializes in deploy learning techniques using digital technology to help clinical leaders design and deliver a personalized curriculum that measurably improves clinical judgment, critical thinking, and patient care. The firm delivers personalized, adaptive lifelong learning solutions. Its proprietary learning platform delivers personalized, mastery-based education and point of care tools both synchronous and asynchronous with care. The company was founded by Mary Ellen Beliveau and is headquartered in Bethesda, MD.

Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA.

F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom.

Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA.

F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom.